Bleakley Financial Group’s Steris STE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
– Sell
-1,078
Closed -$222K – 924
2024
Q4
$222K Sell
1,078
-602
-36% -$132K 0.01% 916
2024
Q3
$407K Buy
1,680
+134
+9% +$31.3K 0.01% 660
2024
Q2
$339K Buy
1,546
+103
+7% +$22.4K 0.01% 722
2024
Q1
$324K Sell
1,443
-10
-0.7% -$2.26K 0.01% 737
2023
Q4
$319K Sell
1,453
-128
-8% -$27.1K 0.01% 716
2023
Q3
$347K Sell
1,581
-250
-14% -$56.6K 0.01% 642
2023
Q2
$412K Buy
1,831
+67
+4% +$13.4K 0.01% 639
2023
Q1
$337K Sell
1,764
-51
-3% -$9.86K 0.01% 676
2022
Q4
$335K Buy
+1,815
New +$319K 0.01% 667

Other funds holding STE

Bleakley Financial Group's STE Position: Q1 2025 in Review

Bleakley Financial Group sold out of Steris (STE) in Q1 2025, closing a stake of 1,078 shares — an estimated $222K sold.

Bleakley Financial Group first reported a position in STE in Q4 2022 and held it in 9 quarters. The position peaked at $412K in Q2 2023. 782 funds tracked by Wall St. Rank hold STE as of Q1 2025.

  • Bleakley Financial Group reported no remaining Steris position as of Q1 2025 after selling out during the quarter.
  • Bleakley Financial Group sold 1,078 Steris shares in Q1 2025, an estimated $222K.
  • Bleakley Financial Group first reported a position in Steris in Q4 2022 and held it in 9 quarters.
  • Bleakley Financial Group's Steris position peaked at $412K in Q2 2023.
  • 782 funds tracked by Wall St. Rank held Steris as of Q1 2025.

Based on Bleakley Financial Group's 13F filing for Q1 2025, filed 1 May 2025.